Cooley advised TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, on its definitive business combination agreement with TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX. Congratulations to TriGemX Bio and to the Cooley team led by Divakar Gupta, William Sorabella, Eric Blanchard, Julia Kim and Susan Choy, with support from Michael Bergmann, Christopher Kimball, Madhuri (Mani) Roy, Alison Freeman-Gleason, Natasha Leskovsek, Sharon Connaughton, Jennifer Shanley, Phil Mitchell, Stephanie Gentile, Todd Gluth, Julie Paulino Montejo, Kevin Cheng, William Friend, Chelsea Braun, Josh Holtzman, Matthew Choy and Calvin Lee. 👉 Read more: https://bit.ly/4zRyRUg
About us
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation. Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people. Attorney Advertising: This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you and Cooley LLP, Cooley (UK) LLP, Cooley SG LLP, Cooley HK or any other Cooley entity (collectively referred to as “Cooley”). By reviewing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice, and it is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. This content may be considered attorney advertising. Do not send any confidential information to Cooley, as we do not have any duty to keep it confidential. Cooley’s privacy policy: https://bit.ly/CooleyLLPprivacy
- Website
-
http://www.cooley.com
External link for Cooley LLP
- Industry
- Law Practice
- Company size
- 1,001-5,000 employees
- Headquarters
- Palo Alto, CA
- Type
- Partnership
- Founded
- 1920
- Specialties
- law firm, venture capital, private equity, legal advice, going private, incorporation, litigation, technology, life sciences, clean tech, licensing, patent, litigation, trademark, employment, bankruptcy, restructuring, and ESOP
Employees at Cooley LLP
Locations
-
Primary
Get directions
3175 Hanover Street
Palo Alto, CA 94304, US
Updates
-
That’s a wrap on this year’s VIVA retreat in Montana. Thank you to the founders, investors and industry leaders who joined Cooley, PwC, Silicon Valley Bank, Fortis Advisors LLC and Gallagher for a few memorable days of meaningful conversations, new connections and time together beyond the usual conference setting. We’re grateful to everyone who helped make this year’s VIVA such a special experience.
-
-
-
-
-
+2
-
-
Cooley advised Kalshi, the first US federally regulated exchange where you can trade on the outcome of any event, on its $1 billion Series G round at a $40 billion post-money valuation, co-led by Wellington and Sequoia. Congratulations to Kalshi and to the Cooley team led by Kevin K. Rooney, Scott D. Rudin, Michael Perretta, John McDonough, Kerry Vance, CPA, Amelia Griffiths and Eric Popp. ➡️ Read more: https://bit.ly/4sxi2eZ
-
-
The Delaware Supreme Court has issued an important decision involving the Verisk-Acculynx deal, affirming that Verisk Analytics could not terminate its $2.35 billion agreement to acquire AccuLynx after FTC review extended beyond the outside date. The decision underscores how post-signing conduct and termination provisions can keep buyers bound beyond a deal deadline. 💡 Read key considerations for general counsel, boards and management teams from Cooley’s Polina Demina, Rishab Kumar, Miguel Vega, Megan Browdie and Norm Armstrong: https://bit.ly/3UkaTC8
-
-
Cooley advised Gattaca, a venture-backed blockchain infrastructure company based in London, on its acquisition of Blink Labs, a platform that helps wallets and applications route and protect their users' transactions. Congratulations to Gattaca and to the Cooley team led by Jonathan Cohen, Laurence Nelson, Maddie Drabble, David Wilson, Eerik Kukebal, Nicola Squire, Christopher Stack, Kafeel Azher, Eric Davison and Caroline Hobson. 👉 Read more: https://bit.ly/4zgIU5w
-
-
Cooley’s Pang Lee and Xin (Joyce) Wang co-authored an article in the Global Private Capital Association (GPCA)’s Legal & Regulatory Journal examining venture studios as an emerging model for creating and scaling new companies, including key considerations involving structuring, IP rights, governance and investor protections.
-
Cooley advised Instacart, a leading grocery technology company, on its $17 billion definitive merger agreement with DoorDash, an online delivery demand aggregator building the future of local commerce by connecting people to the best of their neighborhoods. Congratulations to Instacart and to the Cooley team led by Jon Avina, Jamie Leigh, Kevin Cooper, Milson Yu and Kyle Hess, with support from Nyron Persaud, Tracy Rubin, Ariane A., Michael Mencher, Nikki Chang DiFederico, Julia Gage, Elaine Huang, Christopher Rebagliati, Shukra S., Talea Seyed and Zi Ye. ➡️ Read more: https://bit.ly/3UiAF9P
-
-
Are you a first-year student pursuing qualification as a solicitor in England and Wales? Cooley’s UK Diversity Fellowship is now open for applications from students passionate about promoting diversity, equity and inclusion. Fellows are offered ongoing mentoring, connection and relationship-building opportunities, as well as a bursary of up to £12,000 to assist with university and law school tuition in the UK. ✏️ Learn more and apply: https://bit.ly/4i6q6OR
-
-
Tariff enforcement is entering a new era, as the US government ramps up scrutiny of trade fraud and turns to AI to detect potential violations. In a new Law360 piece, Cooley’s Amanda A. Main, Andrew Goldstein, Will Pao and Bingxin Wu analyze the growing use of AI in trade fraud enforcement, the risks it creates for companies with global supply chains and key considerations for strengthening compliance amid increased scrutiny: https://bit.ly/4ev5Bue
-
Cooley advised CORXEL Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for obesity and related cardiometabolic conditions, on its definitive business combination agreement with Amanat Acquisition Corp., a publicly traded special purpose acquisition company. Congratulations to Corxel Pharmaceuticals and to the Cooley team led by Divakar Gupta, Rama Padmanabhan, Lindsey (O'Crump) Crow, Minkyu Park, Ruomu Li, Will Cai, Mark Ballantyne, Hengda (Michael) Shen and Susan Choy, with support from Alessandra Murata, Alexander (Xander) Lee, Ariane A., Helenanne Connolly, Sharon Connaughton, Rajdeep Roger Bains, Brenna McGuire, Ama Zaniker-Gomez, Benjamin Shulman, John DelMastro, Virat Gupta, Hardy Zhou, Sean R., Shelby Saunders and Jason Valentine. 👉 Read more: https://bit.ly/3ULlfLo
-